MedTrace Logo

PainChek® US Validation Nursing Home Study

NCT06049732 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2024-11-06

No results posted yet for this study

Summary

Pain is common amongst people living with dementia. However, as people's dementia worsens their ability to self-report pain diminishes because of limitations in their cognition and communication abilities. As a result pain in people with moderate to severe dementia often goes under-recognised and undertreated.

PainChek® is a technology-enabled, observational pain assessment tool, in the form of a mobile application designed specifically to assist healthcare professionals and professional caregivers assess pain in people with moderate severe dementia. In this study the investigators aim to assess the performance of PainChek® in assessing pain in nursing home residents with moderate to severe dementia compared to the Abbey Pain Scale.

Conditions

Interventions

DEVICE

PainChek®

Both PainChek® and the Abbey Pain Scale are observational pain assessment tools which have been designed to assist healthcare professionals and profession caregivers assess pain in people who cannot self-report their pain

Sponsors & Collaborators

  • Donawa Lifescience Consulting SRL

    collaborator UNKNOWN

  • TechnoSTAT Clinical Services

    collaborator UNKNOWN

  • PainChek Ltd

    lead INDUSTRY

Principal Investigators

  • Kim Bergen-Jackson, PhD · Christian Retirement Services, Inc (Oaknoll)

  • Wingyun Mak, PhD · The New Jewish Home

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-17
Primary Completion
2024-06-18
Completion
2024-09-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06049732 on ClinicalTrials.gov